Biosense Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.74 M
as on 24-10-2024
- Paid Up Capital ₹ 0.66 M
as on 24-10-2024
- Company Age 16 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 12.00 Cr
as on 24-10-2024
- Revenue -15.56%
(FY 2023)
- Profit 55.37%
(FY 2023)
- Ebitda 102.46%
(FY 2023)
- Net Worth 191.29%
(FY 2023)
- Total Assets -7.92%
(FY 2023)
About Biosense Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.74 M and a paid-up capital of Rs 0.66 M.
The company has closed loans amounting to ₹12.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Tripathi, Alok Kumar, and Narendra Makkar serve as directors at the Company.
- CIN/LLPIN
U85100MH2008PTC188729
- Company No.
188729
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2008
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biosense Technologies Private Limited offer?
Biosense Technologies Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Hematology Analyzers, Surgical & ICU Equipments, Pulse Oximeter, Glucometer & POCT Devices.
Who are the key members and board of directors at Biosense Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Tripathi  | Director | 07-Nov-2019 | Current |
| Alok Kumar | Director | 07-Nov-2019 | Current |
Narendra Makkar  | Director | 07-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Biosense Technologies.
Biosense Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.56% decrease. The company also saw a substantial improvement in profitability, with a 55.37% increase in profit. The company's net worth Soared by an impressive increase of 191.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biosense Technologies?
In 2023, Biosense Technologies had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orchid Biomedical Systems Private LimitedActive 34 years 9 monthsDeepak Tripathi, Alok Kumar and 1 more are mutual person
- Tulip Diagnostics Private LimitedActive 36 years 5 days
Deepak Tripathi, Alok Kumar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 19 Jun 2018 | ₹11.00 Cr | Satisfied |
Indian Bank Creation Date: 13 Feb 2017 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Biosense Technologies?
Biosense Technologies has a workforce of 64 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biosense Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosense Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
